ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.33
1.50%
US Tech 100
19,167.20
2.31%
S&P 500
5,638.94
2.13%
US Dollar vs CAD
1.43865
-0.01%
Bitcoin
83,917.79
-0.05%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Leap Therapeutics Inc (LPTX)

  7. Leap Therapeutics Inc (LPTX) News

LPTX

Leap Therapeutics (LPTX)

Leap Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:LPTX
DateTimeSourceHeadlineSymbolCompany
01/28/20257:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPTXLeap Therapeutics Inc
01/28/20256:00AMPR Newswire (US)Leap Therapeutics Reports Initial Clinical Data from Part B of the DeFianCe Study and Part C of the DisTinGuish StudyNASDAQ:LPTXLeap Therapeutics Inc
01/06/20256:00AMPR Newswire (US)Leap Therapeutics to Participate at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:LPTXLeap Therapeutics Inc
11/26/20246:00AMPR Newswire (US)Leap Therapeutics to Participate at Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:LPTXLeap Therapeutics Inc
11/13/20246:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPTXLeap Therapeutics Inc
11/13/20246:00AMPR Newswire (US)Leap Therapeutics Reports Third Quarter 2024 Financial ResultsNASDAQ:LPTXLeap Therapeutics Inc
11/13/20245:50AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LPTXLeap Therapeutics Inc
11/06/20243:31PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:LPTXLeap Therapeutics Inc
10/31/20245:29PMEdgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:LPTXLeap Therapeutics Inc
10/31/20244:40PMEdgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:LPTXLeap Therapeutics Inc
10/04/20244:29PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LPTXLeap Therapeutics Inc
10/04/20244:29PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LPTXLeap Therapeutics Inc
10/04/20244:27PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LPTXLeap Therapeutics Inc
10/04/20244:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LPTXLeap Therapeutics Inc
10/04/20244:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LPTXLeap Therapeutics Inc
10/04/20244:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LPTXLeap Therapeutics Inc
10/04/20244:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LPTXLeap Therapeutics Inc
10/04/20244:23PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LPTXLeap Therapeutics Inc
09/30/20246:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPTXLeap Therapeutics Inc
09/30/20246:00AMPR Newswire (US)Leap Therapeutics Announces Completion of Enrollment in Part B of the DeFianCe Study of DKN-01 for the Treatment of Colorectal Cancer PatientsNASDAQ:LPTXLeap Therapeutics Inc
08/12/20246:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPTXLeap Therapeutics Inc
08/12/20246:00AMPR Newswire (US)Leap Therapeutics Reports Second Quarter 2024 Financial ResultsNASDAQ:LPTXLeap Therapeutics Inc
08/12/20245:50AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LPTXLeap Therapeutics Inc
07/08/20243:48PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPTXLeap Therapeutics Inc
05/23/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LPTXLeap Therapeutics Inc
05/23/20243:25PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:LPTXLeap Therapeutics Inc
05/13/20246:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPTXLeap Therapeutics Inc
05/13/20246:00AMPR Newswire (US)Leap Therapeutics Reports First Quarter 2024 Financial ResultsNASDAQ:LPTXLeap Therapeutics Inc
05/13/20245:50AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LPTXLeap Therapeutics Inc
05/10/20244:01PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:LPTXLeap Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:LPTX

Your Recent History

NYSE
BVN
Compania De Minas Buenav...
BIT
S29358
Societe Generale Effekten
NYSE
PPL
PPL
NYSE
PGR
Progressive
NYSE
MOH
Molina Healthcare
NYSE
RMD
ResMed
NYSE
PLD
Prologis
BIT
S28653
Societe Generale Effekten
TG
6WS
Wise
TSX
ATZ
Aritzia
AMEX
EWV
ProShares UltraShort MSC...
AMEX
IEO
iShares US Oil & Gas Exp...
BIT
F34759
Vontobel Financial Produ...
LSE
GLUG
Lg Water Etf
BIT
S29659
Societe Generale Effekten
BIT
S29011
Societe Generale Effekten
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads